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Case report
Calcified amorphous tumor: A rare cause of central retinal artery occlusion
Jeffrey H. Ma, Manjot K. Gill∗
Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
A R T I C L E I N F O
Keywords:
Central retinal artery occlusion
Calcified amorphous tumor
Mitral annular calcification
A B S T R A C T
Purpose: We report the case of a central retinal artery occlusion secondary to presumed embolus from a calcified
amorphous tumor of the heart, a very rare non-neoplastic cardiac mass.
Observations: A 60-year-old female presented with acute unilateral vision loss of the left eye. Examination re-
vealed hand motion visual acuity of the left eye and a left relative afferent pupillary defect. Fundoscopy showed
whitening of the macula with a cherry red spot, consistent with a central retinal artery occlusion. Initial workup
was unremarkable, including hypercoagulability labs, magnetic resonance imaging of the brain, and magnetic
resonance angiography of the head and neck. Transthoracic echocardiogram (TTE) showed calcification of the
mitral valve but no masses. Subsequently, transesophageal echocardiogram (TEE) was performed, which re-
vealed a mobile calcified amorphous tumor of the heart.
Conclusions: Calcified amorphous tumor of the heart is a very rare cardiac mass that may cause retinal artery
occlusion. TEE is a more sensitive imaging modality to assess for potential cardio-embolic sources if TTE is
unrevealing.
1. Introduction
While cardio-embolic sources are the second most common cause of
retinal artery occlusions after carotid artery disease, calcified amor-
phous tumor (CAT) of the heart is a very rare cardiac mass with only 2
reports in the literature of its association with retinal artery occlu-
sion.1,2 We report a case of central retinal artery occlusion due to
presumed calcific embolus from a CAT which was initially missed on
transthoracic echocardiogram (TTE) and subsequently detected on
transesophageal echocardiogram (TEE).
2. Case report
A 60-year-old female presented as a consult to the retina clinic with
a history of sudden vision loss of the left eye, which had occurred 2
months prior. She had initially presented to a local hospital where she
was diagnosed with a left central retinal artery occlusion (CRAO) that
was acutely managed with ocular massage and anterior chamber
paracentesis. The patient then transferred care to our hospital. She had
a past medical history of ovarian cancer in remission, type 2 diabetes
with mild non-proliferative diabetic retinopathy, and morbid obesity.
On initial presentation, her best-corrected visual acuity was hand mo-
tion in the left eye. Fundus examination of the left eye showed a pale
retina with a cherry red spot in the fovea, as well as occlusions of the
retinal arteries, consistent with a CRAO. Laboratory tests, including
complete blood count, hypercoagulability studies (anticardiolipin an-
tibody, lupus anticoagulant, antithrombin III activity, protein C ac-
tivity, protein S activity, homocysteine), erythrocyte sedimentation
rate, and C-reactive protein, were within normal limits. Magnetic re-
sonance imaging of the brain showed no acute infarcts, and magnetic
resonance angiography of the head and neck showed no occlusions or
significant stenosis of the carotid or vertebral circulations. TTE with
bubble study showed mitral annular calcification but no masses.
Subsequently, TEE was performed, which revealed severe caseous mi-
tral annular calcification of the posterior mitral valve, as well as a
mobile 0.9× 1.0 cm calcified endocavitary mass of the mitral valve
that was diagnosed as a calcified amorphous tumor of the heart and the
presumed source of her CRAO (Fig. 1). The patient was evaluated by the
cardiac surgery service whereupon she was deemed a poor surgical
candidate for cardiac exploration and mass resection given her morbid
obesity. She was started on aspirin and warfarin for anticoagulation,
with reconsideration for possible surgery if she were to develop re-
current thromboembolic events or valvular compromise.
On her presentation to the retina service 2 months later, her visual
acuity in the left eye remained hand motion, with a left relative afferent
pupillary defect. Her fundus exam was significant for perifoveal
whitening, arteriolar attenuation, and pallor of the optic nerve with fine
neovascularization of the disc (Fig. 2A and B). Fluorescein angiography
revealed an enlarged foveal avascular zone with disc leakage and per-
ipheral vascular staining (Fig. 3A and B). She was treated with
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panretinal photocoagulation of the left eye with regression of neo-
vascularization. She has had no other complications related to her
cardiac tumor since then.
3. Discussion
First described in 1997 by Reynolds et al.,3 calcified amorphous
tumor is a very rare non-neoplastic cardiac mass formed from a de-
generating mural thrombus. While the pathogenesis of CAT is poorly
understood, histological studies show nodular calcium deposits sur-
rounded by amorphous degenerated fibrin, hyaline and inflammatory
cells.3–5 In a review of all 42 reported cases of CAT from 1997 to 2015,
14% were associated with mitral annular calcification, which is chronic
degeneration and calcification of the mitral valve affecting about 10%
of the population.6 CAT may represent the end result of caseous
transformation and liquefaction of mitral annular calcification. Patients
typically present with dyspnea, syncope and pulmonary embolism. To
our knowledge, there have been only 2 previous reports of retinal artery
embolism resulting from cardiac CAT.1,2 We report a case of CRAO due
to presumed embolus from a cardiac CAT that was initially missed on
TTE, though the possibility of an arteriosclerotic thrombus causing her
CRAO cannot be entirely ruled out. Surgical resection is considered the
definitive treatment of a cardiac CAT although observation with an-
ticoagulation therapy is sometimes elected if calcium infiltration is
extensive or surgical morbidity is high.
Our current case demonstrates the utility of TEE in evaluating for
potential cardio-embolic sources that may be missed by TTE. In our
patient, TTE demonstrated only mitral annular calcification, while
cardiac CAT was only detected on subsequent TEE. Prior studies have
reported the higher yield of TEE over TTE in detecting cardiac or aortic
abnormalities in patients with retinal artery occlusion.7–9 In a study by
Kramer et al., 11 of 18 patients (61%) with retinal artery occlusion had
at least one potential cardiac or aortic source of retinal emboli found on
TEE that was missed by TTE.10 Thus, TEE is a useful imaging modality
that should be considered especially in a patient with retinal artery
occlusion with an otherwise unrevealing workup for emboli.
4. Conclusions and importance
Calcified amorphous tumor of the heart is a very rare cause of ret-
inal artery occlusion. This case highlights the utility of transesophageal
echocardiography as part of a thorough workup for detecting cardiac
Fig. 1. Fundus photos of the right (A) and left (B)
eyes reveals perifoveal whitening, disc pallor and
vascular attenuation of the left eye 2 months after
initial central retinal artery occlusion.
Fig. 2. Fluorescein angiogram of the left eye shows early hyperfluorescence of the disc and an enlarged foveal avascular zone (A), with disc leakage and peripheral vascular staining in the
late phase (B).
Fig. 3. Transesophageal echocardiogram shows calcification of the posterior mitral valve
annulus with an echodense mass (arrow) attached to the mitral valve consistent with
calcified amorphous tumor of the heart. LA= left atrium; LV= left ventricle; Ao= aorta.
J.H. Ma, M.K. Gill American Journal of Ophthalmology Case Reports 10 (2018) 25–27
26
sources of retinal emboli, particularly when transthoracic echocardio-
graphy is unrevealing.
Patient consent
Consent to publish the case report was not obtained. This report
does not contain any personal information that could lead to the
identification of the patient.
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